Form 4 for MDT Medtronic
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001613103-25-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-05 | 2025-03-03 | MDT | Pieton Thierry | EVP, CFO | A - Grant | $94.30 | +30.8K | 4,242 | New | +$2.90M |
| DM | 2025-03-05 | 2025-03-03 | MDT | Pieton Thierry | EVP, CFO | A - Grant | $0.00 | +40.2K | 10.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-03 | A | A | 26,512 | $94.30 | 30,754 | D | — | — | (F2) Represents restricted stock units that vest in three annual installments beginning one year from the date of grant. |
| 2 | Common | Ordinary Shares | 2025-03-03 | A | A | 4,242 | $94.30 | 4,242 | D | — | — | (F1) Represents restricted stock units that vest 100% on the third anniversary of the date of grant. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-03-03 | A | A | 29,574 | $0.00 | 29,574 | D | $94.30 · — to 2035-03-03 | 29,574 Ordinary Shares | (F6) The options are exercisable in four annual installments beginning one year from the date of grant. |
| 4 | Derivative | Performance Share Unit | 2025-03-03 | A | A | 10,605 | $0.00 | 10,605 | D | — · — to — | 10,605 Performance Share Units | (F3) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F4) Vests on April 30, 2027. |